[HTML][HTML] T cell dysfunction and exhaustion in cancer
Z Zhang, S Liu, B Zhang, L Qiao, Y Zhang… - Frontiers in cell and …, 2020 - frontiersin.org
Tumor immunotherapy is a promising therapeutic strategy for patients with advanced
cancers. T cells are key mediators of antitumor function that specifically recognize and react …
cancers. T cells are key mediators of antitumor function that specifically recognize and react …
T Cell Dysfunction and Exhaustion in Cancer
Z Zhang, S Liu, B Zhang, L Qiao… - Frontiers in cell and …, 2020 - pubmed.ncbi.nlm.nih.gov
Tumor immunotherapy is a promising therapeutic strategy for patients with advanced
cancers. T cells are key mediators of antitumor function that specifically recognize and react …
cancers. T cells are key mediators of antitumor function that specifically recognize and react …
[HTML][HTML] T Cell Dysfunction and Exhaustion in Cancer
Z Zhang, S Liu, B Zhang, L Qiao… - Frontiers in Cell and …, 2020 - ncbi.nlm.nih.gov
Tumor immunotherapy is a promising therapeutic strategy for patients with advanced
cancers. T cells are key mediators of antitumor function that specifically recognize and react …
cancers. T cells are key mediators of antitumor function that specifically recognize and react …
T Cell Dysfunction and Exhaustion in Cancer
Z Zhang, S Liu, B Zhang, L Qiao… - Frontiers in Cell and …, 2020 - scholars.northwestern.edu
Tumor immunotherapy is a promising therapeutic strategy for patients with advanced
cancers. T cells are key mediators of antitumor function that specifically recognize and react …
cancers. T cells are key mediators of antitumor function that specifically recognize and react …
[引用][C] T Cell Dysfunction and Exhaustion in Cancer
Z Zhang, S Liu, B Zhang, L Qiao, Y Zhang - Frontiers in Cell and …, 2020 - cir.nii.ac.jp
T Cell Dysfunction and Exhaustion in Cancer | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
T Cell Dysfunction and Exhaustion in Cancer
Z Zhang, S Liu, B Zhang, L Qiao, Y Zhang - 2020 - agris.fao.org
Tumor immunotherapy is a promising therapeutic strategy for patients with advanced
cancers. T cells are key mediators of antitumor function that specifically recognize and react …
cancers. T cells are key mediators of antitumor function that specifically recognize and react …
[引用][C] T Cell Dysfunction and Exhaustion in Cancer
Z Zhang, S Liu, B Zhang, L Qiao… - Frontiers in Cell and …, 2020 - jglobal.jst.go.jp
Ahmed N., Brawley V., Hegde M., Bielamowicz K., Kalra M., Landi D., et al (2017). HER2-
specific chimeric antigen receptor-modified virus-specific T cells for progressive …
specific chimeric antigen receptor-modified virus-specific T cells for progressive …
T Cell Dysfunction and Exhaustion in Cancer
Z Zhang, S Liu, B Zhang, L Qiao… - Editor's Pick 2021 …, 2022 - books.google.com
Tumor immunotherapy is a promising therapeutic strategy for patients with advanced
cancers. T cells are key mediators of antitumor function that specifically recognize and react …
cancers. T cells are key mediators of antitumor function that specifically recognize and react …
T Cell Dysfunction and Exhaustion in Cancer.
Z Zhang, S Liu, B Zhang, L Qiao… - Frontiers in Cell and …, 2020 - europepmc.org
Tumor immunotherapy is a promising therapeutic strategy for patients with advanced
cancers. T cells are key mediators of antitumor function that specifically recognize and react …
cancers. T cells are key mediators of antitumor function that specifically recognize and react …